Menu
Log in


Canadian Society of

Pharmacology and Therapeutics

Log in
Welcome!

Thank you for being a valued member. Take advantage of all the benefits your membership includes and don't forget to renew.

Log in

CSPT Member log-In / Reset Password / View & Edit Profile

For laptop and desktop users, click the blue person icon located on the left or on top right of your screen.

For mobile (phone) and tablet users, click the black arrow icon located on the top right of your screen.


CSPT membership APP for your iphone, ipad, Android device, and Chromebook.

Apple APP Store


Upcoming events

    • Tuesday, March 07, 2023
    • 1:30 PM - 2:30 PM
    • Virtual Meeting - Link will be sent to all registrants 30 minutes prior to the event
    Register

    Register to receive the virtual meeting link for
    our upcoming webinar joint with ASPET's Drug Metabolism and Disposition Division  

    Current Advances in Drug Metabolism - Industry Focus 

    Hear from

    Robert S. Jones, Ph.D.,
    Principal Scientist, Drug Metabolism & Pharmacokinetics,
    Genetech, San Francisco, California
    on
    "Application of empirical scalars to enable early prediction of human hepatic clearance using in vitro-in vivo extrapolation in drug discovery" 

    Dr. Robert S. Jones is currently a Principal Scientist in the department of Drug Metabolism and Pharmacokinetics (DMPK) at Genentech Inc. There he works within the PK/Transport Group to develop translational in vitro models and in silico approaches for improving the translation of preclinical data to human, both from a project, and investigative research perspective. In this webinar, Dr. Jones will discuss a recently published approach utilizing empirical scalars on early drug discovery data to improve current predictions of human clearance 

    and from 

    Sebastian D. Parlee, Ph.D.,
    Sr. D&I Engagement Partner, Organizational Effectiveness, R&ED Executive Office,
    Novo Nordisk, Boston, Massachusetts
    on
    "Innovation through Diversification: Novo Nordisk Research & Early Development Essential #6 Strategy" 

    Our Fundamental goal in Research and Early Development (R&ED) at Novo Nordisk is to identify and develop next generation life saving medicines for our patients. An inclusive culture is a prerequisite for this as our people must feel safe to bring their whole selves to work and challenge the status quo for innovation to occur. In this webinar, our philosophy, values and strategy for building this respectful global culture as well as attracting and unifying diverse talent will be presented


Sponsors & Partners section

Canadian Society of Pharmacology and Therapeutics

email: info@pharmacologycanada.org

Copyright © 2020 CSPT. All rights reserved.

Powered by Wild Apricot Membership Software